Table 4 Characteristics of patients with and without high risk EV
Characteristic | Low risk (n = 29) | High risk (n = 10) | P value |
|---|---|---|---|
Age (years) | 65 (13–90) | 54 (14–74) | 0.145 |
Male | 17 (59) | 8 (80) | 0.279 |
Body mass index | 24.3 (17.3–41.1) | 25.0 (18.5–30.2) | 0.530 |
Etiology | |||
NAFLD/NASH | 4 (14) | 3 (30) | 0.500 |
HBV | 10 (34) | 0 (0) | 0.083 |
PBC | 4 (14) | 1 (10) | 0.811 |
ALD | 6 (21) | 4 (40) | 0.432 |
Other | 5 (17) | 2 (20) | 0.778 |
Platelet count (×109/l) | 118 (39–683) | 55 (34–99) | 0.039 |
AST (IU/l) | 30 (17–146) | 42 (15–120) | 0.326 |
ALT (IU/l) | 24 (8–86) | 29 (9–123) | 0.367 |
Albumin (g/dl) | 3.9 (2.7–4.6) | 3.5 (3.0–4.2) | 0.055 |
T.Bil (mg/dl) | 1.0 (0.5–7.5) | 2.4 (0.4–7.1) | 0.014 |
PT% | 78 (40–95) | 64 (27–92) | 0.004 |
LS (kPa) | 7.7 (3.5–75.0) | 24.9 (9.1–75.0) | 0.004 |
Spleen size (cm) | 10.3 (6.1–24.0) | 13.9 (7.7–16.6) | 0.050 |
LSPS | 1.0 (0.1–9.5) | 5.5 (1.2–20.0) | <0.001 |
APRI | 1.1 (0.1–4.8) | 2.4 (0.8–4.0) | 0.026 |
FIB-4 | 4.2 (0.1–12.0) | 8.4 (1.2–10.9) | 0.044 |
Platelet-to-spleen ratio | 1092 (225–5591) | 407 (220–770) | 0.003 |